शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
AMBALALSABSEAMBALAL SARABHAI ENT L· Pharmaceuticals & BiotechnologyHighNeutral
Announced Thu, 5 Nov, 2026 · 16:15 IST

Consolidated September 2026 quarter revenue rises 31% and profit turns positive

Revenue growth above 20%EBITDA margin expansionResults restatedResults View source PDFExplain this filing

AMBALALSA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-3.3%Reaction day
₹36.50
prior close
₹37.00
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is usedpendingvs market: pending
Pharmaceuticals peers, median of 173sector-0.2%-3.1% vs sector

On the reaction day the stock moved 3.1 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-2.7
10m
-2.7
15m
-4.7
30m
-4.3
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-3.3pendingpending-0.2-3.1
Next day
—————
2d
—————
3d
—————
4d
—————
5d
—————
1w
—————
15d
—————
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 173Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

For the consolidated quarter ended 30 September 2026, revenue was Rs 5,813.39 lakh, up 30.8% from Rs 4,444.92 lakh a year earlier, and profit after tax was Rs 67.49 lakh versus a Rs 56.03 lakh loss. Standalone quarter revenue was Rs 57.50 lakh versus Rs 78.92 lakh a year earlier, with a Rs 3.03 lakh loss versus Rs 38.23 lakh. Consolidated half-year revenue was Rs 10,169.65 lakh and profit after tax Rs 465.07 lakh, down from Rs 766.32 lakh.

Likely market impact

Positive: revenue rose 31% and quarterly profit turned positive, but half-year profit fell to Rs 465.07 lakh from Rs 766.32 lakh.

By the numbers

The filed figures for this quarter have not reached us in XBRL yet, so there is nothing to compute here; the read above is the AI's, from the document. The table appears the moment the figures land.